Xgeva and Ear disorder - a phase IV clinical study of FDA data

Summary:

Ear disorder is reported as a side effect among people who take Xgeva (denosumab), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Ibrance, and have Breast cancer female.

The phase IV clinical study analyzes which people have Ear disorder when taking Xgeva. It is created by eHealthMe based on reports of 37,636 people who have side effects when taking Xgeva from the FDA, and is updated regularly.

What is Xgeva?

Xgeva has active ingredients of denosumab. It is often used in breast cancer. eHealthMe is studying from 37,717 Xgeva users. Check the latest studies of Xgeva.

What is Ear disorder?

Ear disorder is found to be associated with 593 drugs and 1,110 conditions by eHealthMe. Check the latest studies of Ear disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

37,636 people reported to have side effects when taking Xgeva.
Among them, 17 people (0.05%) have Ear disorder.

Among these 17 people:

How long have people been on Xgeva when they have Ear disorder? *

What is the gender of people who have Ear disorder when taking Xgeva? *

female: 100 %
male: 0.0 %

What is the age of people who have Ear disorder when taking Xgeva? *

What are other drugs people take besides Xgeva? *

What are other side effects people have besides Ear disorder? *

Joint Pain: 11 people, 64.71%
White Blood Cell Count Decreased: 11 people, 64.71%
Ear Pain: 10 people, 58.82%
Dry Skin: 9 people, 52.94%
Fatigue (feeling of tiredness): 9 people, 52.94%
Feeling Abnormal: 9 people, 52.94%
Hair Loss: 8 people, 47.06%
Hypoacusis (loss of hearing): 8 people, 47.06%
Headache (pain in head): 8 people, 47.06%
White Blood Cell Disorder: 7 people, 41.18%

What are the existing conditions these people have? *

Breast Cancer Female: 8 people, 47.06%
Breast Cancer Metastatic: 7 people, 41.18%
Stress And Anxiety: 4 people, 23.53%
Indigestion: 4 people, 23.53%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 4 people, 23.53%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 17.65%
Dyspnea (difficult or laboured breathing): 3 people, 17.65%
Bone Disorder: 3 people, 17.65%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 17.65%
Multiple Myeloma (cancer of the plasma cells): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Xgeva and have Ear disorder?

- Check whether Ear disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xgeva:

Xgeva (37,717 reports)

Ear disorder treatments and more:

Ear disorder (6,288 reports)

Browse all side effects of Xgeva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ear disorder:

Ear disorder (593 drugs)

Browse all the conditions that are associated with Ear disorder:

Ear disorder (1,110 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on denosumab (the active ingredients of Xgeva) and Xgeva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.